Physician profile
Rajeev Bhatia
NPI 1417141789
$5,516.09
in general payments reported to CMS, 2019-2025
17 companies · $1,150 in 2025
The $1,150 reported for 2025 was more than what 89% of Pediatric Pulmonology providers received nationally (typical 2025 total: $140).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $707 · 2020: $589 · 2021: $801 · 2022: $1,457 · 2023: $39.17 · 2024: $773 · 2025: $1,150.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,500 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $369 · Food and Beverage: $93.18.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,500.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $368.63 |
| Food and Beverage | $93.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $4,170.00 | 2019-2025 | |
| Vyaire Medical, INC. | $441.15 | 2022 | |
| Aero US INC | $368.63 | 2025 | Aerogen Solo Nebulizer System, Aerogen Usb Controller System, Aerogen Solo; Aerogen Ultra |
| Glaxosmithkline, LLC. | $165.73 | 2019-2021 | |
| Vertex Pharmaceuticals Incorporated | $49.72 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $45.07 | 2019 | |
| Sobi, INC | $40.34 | 2019 | |
| Genentech USA, INC. | $38.74 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $37.74 | 2019-2023 | |
| Genzyme Corporation | $36.40 | 2019-2024 | |
| Tactile Systems Technology INC | $31.09 | 2025 | Nimbl, Flexitouch Plus |
| Vapotherm INC | $18.99 | 2020 | |
| Abbvie INC. | $16.19 | 2022 | |
| Pari Respiratory Equipment, INC. | $14.95 | 2021 | |
| Gilead Sciences, INC. | $14.06 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $14.00 | 2019 | |
| Philips North America LLC | $13.29 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rajeev Bhatia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.